Press Releases

REDWOOD CITY, Calif., Jan. 13, 2020 /PRNewswire/ -- Revolution Medicines, Inc., a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced that preliminary data from the company's Phase 1 clinical trial (RMC-4630-01) of RMC-4630 were reported in podium and poster pr

STOCKHOLM, Jan. 13, 2020 /PRNewswire/ -- Essity's subsidiary Vinda International Holdings Ltd today published a press release with the title "Inside information and positive profit alert."Link to the press release:

SEATTLE, Jan. 13, 2020 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has closed the 2nd tranche of its Series C round of financing. The proceeds of the financing are being used to support further clinical testing and commerc

LAKEWOOD, Colo., Jan. 13, 2020 /PRNewswire/ -- On January 17, Natural Grocers will celebrate its 3rd annual Resolution Reset D

TEWKSBURY, Mass., Jan. 13, 2020 /PRNewswire/ -- Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced the first Japanese patients were randomized in Toyama and Hyogo under a clinical trial authorization from the Pharmaceutical and Medical Device Agency (PMDA) in the REDUCE LAP-HF II trial. The

NEW YORK, Jan. 13, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium"), announced today that it has entered into an agreement with the University of California, Davis (UC Davis) to utilize Actinium's Antibody Radiation-Conjugate or ARC apamistamab-I-131 for targeted conditioning and replace

SAN FRANCISCO, Jan. 13, 2020 /PRNewswire/ -- Life sciences mergers and acquisitions (M&A) activity, driven by pharmaceutical buyers, totaled an unprecedented US$357b in 2019 (as of 30 November), breaking the 2014 record. Medical technology and biotechnology companies remained on the sidelines, showing life sciences companies did not use their firepower equally.

Survival improvement of over 150% seen in MDNA55 subjects compared to a Synthetic Control Arm TORONTO and HOUSTON, Jan 13, 2020 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it h

REDWOOD CITY, Calif., Jan. 13, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today provided an update on its business and DSUVIA® launch metrics."Exceeding our 2019 formulary app

SAN FRANCISCO and PFÄFFIKON, Switzerland and LONDON, Jan. 13, 2020 /PRNewswire/ -- DiNAQOR AG, a global gene therapy platform company, today announced a